Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Trimeresurus”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 271 records · Page 15Linked to original sources

Substrate specificity of two thrombin like enzymes (elegaxobin, elegaxobin II) from the venom of Trimeresurus elegans (Sakishima-habu), using neutralizing antibody.

We reported previously that elegaxobin and elegaxobin II cause the release of fibrinopeptide A alone from rabbit fibrinogen. Elegaxobin II is a thrombin-like enzyme that possesses kinin-releasing activity, and shows a characterization obviously different from elegaxobin. To study the substrate specificities of elegaxobin and elegaxobin II against fibrinogen, we investigated whether anti-elegaxobin or anti-elegaxobin II antibody counteracts those enzymatic activities. Anti-elegaxobin II antibody effectively counteracted the thrombin-like activity of elegaxobin and elegaxobin II in comparison to the anti-elegaxobin antibody. The anti-elegaxobin II antibody only counteracted the thrombin-like activity, whereas did not counteract TAME hydrolytic activity and weakly counteract the kinin-releasing activity. Furthermore, we investigated which part of elegaxobin II as an antigen this antibody connects with specifically, using M-peptides derived from digests with CNBr. As a result, anti-elegaxobin II antibody bound specifically to the M-peptide including C-terminal portion. In particular, the anti-elegaxobin II antibody connected to position 220-239 (AQPHEPGSYTNVFDHLDWIK), containing His(223).

Amino Acid Sequence↗

Inhibitory effect of habu antivenom on fibrinopeptide A release induced by Trimeresurus flavoviridis crude venom.

The correlation between the clotting activity of crude venom and concentration of fibrinopeptide A (FPA) released by the crude venom in rabbit plasma was evaluated and expressed as the coefficient of correlation (r = 0.850). The venom-induced FPA release was inhibited by habu antivenom. For such inhibition of FPA release, the correlation between the concentration of habu antivenom (Y) and that of crude venom (X) could be expressed by the equation Y = 7.115 + 0.709X. An absence of venom-induced FPA release in rabbit plasma had suggested that the clotting activity of crude venom could be neutralized by the habu antivenom. It is suggested that determinations of the FPA level in the plasma are effective in providing an indication of the reliability for serotherapy using habu antivenom.

Animals↗